NASDAQ:NEUP | Free Cash Flow | Neuphoria Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-06-30 to 2025-09-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$3.79M
2025-06-30-$3.59M
2024-09-30-$4.43M
2024-06-30-$3.01M
2023-09-30-$4.43M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30$77,229.00
2024-06-30-$14.68M
2023-06-30-$14.64M